Abivax SA American Depositary Shares
ABVX Real Time Price USDRecent trades of ABVX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ABVX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Phenyl-n-quinoline derivatives for treating a rna virus infection Sep. 10, 2024
-
Patent Title: Quinoline derivatives for use in the treatment of inflammation diseases May. 28, 2024
-
Patent Title: Combinations including abx196 for the treatment of cancer Nov. 28, 2023
-
Patent Title: Aryl-n-aryl derivatives for treating a rna virus infection Aug. 29, 2023
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases May. 16, 2023
-
Patent Title: Mirna-124 as a biomarker Sep. 13, 2022
-
Patent Title: Compounds useful for treating cancer Aug. 30, 2022
-
Patent Title: Combinations including abx196 for the treatment of cancer Mar. 22, 2022
-
Patent Title: Abx196 for use in the treatment of bladder cancer Mar. 08, 2022
-
Patent Title: Compounds and pharmaceutical compositions containing at least one of the compounds May. 25, 2021
-
Patent Title: Use of quinoline derivatives for the treatment of inflammatory diseases Apr. 20, 2021
-
Patent Title: Compound, and production method thereof, and methods of treatment using the compound Apr. 13, 2021
-
Patent Title: Method of preparation of alpha galactosyl ceramides compounds Dec. 22, 2020
-
Patent Title: Quinoline derivatives for use in the treatment or prevention of viral infection Oct. 20, 2020
-
Patent Title: Compounds useful for treating cancer Jul. 21, 2020
-
Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Jun. 16, 2020
-
Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Jan. 21, 2020
-
Patent Title: Quinoline derivatives for the treatment of inflammatory diseases Oct. 08, 2019
-
Patent Title: Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging Apr. 09, 2019
-
Patent Title: Compounds useful for treating aids Jul. 10, 2018
-
Patent Title: Compounds useful for treating cancer May. 15, 2018
-
Patent Title: Compounds useful for treating aids Mar. 06, 2018
-
Patent Title: Compounds for use as therapeutic agents affecting p53 expression and/or activity Feb. 13, 2018
-
Patent Title: Compounds useful for treating diseases caused by retroviruses Nov. 28, 2017
-
Patent Title: Compounds for treating cancer May. 02, 2017
-
Patent Title: Use of rbm39 as a biomaker Jan. 31, 2017
-
Patent Title: Vaccine composition for use against influenza Dec. 29, 2015
-
Patent Title: Compounds useful for treating aids Sep. 29, 2015
-
Patent Title: Compounds useful for treating cancer Aug. 18, 2015
-
Patent Title: Compounds useful for treating aids Jun. 23, 2015
-
Patent Title: Methods of enhancing adjuvaticity of vaccine compositions Dec. 23, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ABVX in WallStreetBets Daily Discussion
Recent insights relating to ABVX
Recent picks made for ABVX stock on CNBC
ETFs with the largest estimated holdings in ABVX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ABVX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.